The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents

Clinical Oral Investigations

Volumn 15, Issue 2, 2011, Pages 185-192

  van der Putten, Gert Jan ^a   Brand, Henk S ^b   Schols, Jos M G A ^c   de Baat, Cees ^d  

^a BENECOMO   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hyposalivation; Medication; Nursing home; Xerostomia; Xerostomia Inventory

Indexed keywords

DRUG;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; NURSING HOME; QUESTIONNAIRE; SALIVA; SALIVATION; SECRETION; SEX DIFFERENCE; VALIDATION STUDY; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; SALIVA; SALIVATION; SECRETORY RATE; SEX FACTORS; XEROSTOMIA;

EID: 79952697711     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-010-0382-1     Document Type: Article

References (49)

1. Sreebny LM (2000) Saliva in health and disease: an appraisal and update. Int Dent J 50: 140-161.
2. Ship JA, Pillemer SR, Baum BJ (2002) Xerostomia and the geriatric patient. J Am Geriatr Soc 50: 535-543.
3. Orellana MF, Lagravère MO, Boychuk DGJ, Major PW, Flores-Mir C (2006) Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent 66: 152-158.
4. Dormenval V, Budtz-Jørgensen E, Mojon P, Bruyère A, Rapin C-H (1998) Associations between malnutrition, poor general health and oral dryness in hospitalized elderly patients. Age Ageing 27: 123-128.
5. Pajukoski H, Meurman JH, Halonen P, Sulkava R (2001) Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systematic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92: 641-649.
6. Eveson JW (2008) Xerostomia. Periodontology 2000(48): 85-91.
7. Eliasson L, Birkhed D, Carlén A (2009) Feeling of dry mouth in relation to whole and minor gland saliva secretion rate. Arch Oral Biol 54: 263-267.
8. Dawes C (2008) Salivary flow patterns and the health of hard and soft oral tissues. J Am Dent Assoc 139: 18S-24S.
9. Mese H, Matsuo R (2007) Salivary secretion, taste and hyposalivation. J Oral Rehabil 34: 711-723.
10. van den Broek AMWT, Feenstra L, De Baat C (2007) A review of the current literature on aetiology and measurement methods of halitosis. J Dent 35: 627-635.
11. Kagami H, Wang S, Hai B (2008) Restoring the function of salivary glands. Oral Dis 14: 15-24.
12. Kaplan I, Zuk-Paz L, Wolff A (2008) Association between salivary flow rates, oral symptoms, and oral mucosal status. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 235-241.
13. Almståhl A, Wikström A (1999) Oral microflora in subjects with reduced salivary secretion. J Dent Res 78: 1410-1416.
14. Bardow A, Nyvad B, Nauntofte B (2001) Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 46: 414-423.
15. Ikebe K, Matsuda K, Morii K, Wada K, Hazeyama T, Nokubi T et al (2007) Impact of dry mouth and hyposalivation on oral health-related quality of life of elderly Japanese. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 216-222.
16. Mariño R, Schofield M, Wright C, Calache H, Minichiello V (2008) Self-reported and clinically determined oral health status predictors for quality of life in dentate older migrant adults. Community Dent Oral Epidemiol 36: 85-94.
17. Streckfus C, Bigler L, O'Bryan T (2002) Aging and salivary cytokine concentrations as predictors of whole saliva flow rates among women. A preliminary study. Gerontology 48: 282-288.
18. Eliasson L, Carlén A, Laine M, Birkhed D (2003) Minor gland and whole saliva in postmenopausal women using a low potency oestrogen (oestriol). Arch Oral Biol 48: 511-517.
19. Fenoll-Palomares C, Muñoz Mantagud JV, Sanchiz V, Herreros B, Hernández V, Mínquez M et al (2004) Unstimulated salivary flow rate, pH, and buffer capacity of saliva in healthy volunteers. Rev Esp Enferm Dig 96: 773-783.
20. Nagler RM, Hershkovich O (2005) Age-related changes in unstimulated salivary function and composition and its relations to medications and oral sensorial complaints. Aging Clin Exp Res 17: 358-366.
21. Flink H, Bergdahl M, Tegelberg Å, Rosenblad A, Lagerlöf F (2008) Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol 36: 523-531.
22. Kim S-K, Allen ED (1994) Structural and functional changes in salivary glands during aging. Microsc Res Tech 28: 243-253.
23. Vered M, Buchner P, Boldon P, Dayan D (2000) Age-related histomorphometric changes in labial salivary glands with special reference to the Acinar component. Exp Gerontol 35: 1075-1084.
24. Ghezzi EM, Ship JA (2003) Aging and secretory reserve capacity of major salivary glands. J Dent Res 82: 844-848.
25. Ghezzi EM, Wagner-Lange LA, Schork MA, Metter EJ, Baum BJ, Streckfus CF et al (2000) Longitudinal influence of age, menopause, hormone replacement therapy, and other medications on parotid flow rates in healthy women. J Gerontol A Biol Sci Med Sci 55: M34-M42.
26. Patel PS, Ghezzi EM, Ship JA (2001) Xerostomic complaints induced by an anti-sialogogue in healthy young vs. older adults. Spec Care Dent 21: 176-181.
27. Eliasson L, Birkhed D, Österberg T, Carlén A (2006) Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. Eur J Oral Sci 114: 494-499.
28. Ness J, Hoth A, Barnett MJ, Shorr RI, Kaboli PJ (2006) Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptoms burden, and adverse drug events. Am J Geriatr Pharmacother 4: 42-51.
29. Wolff A, Zuk-Paz L, Kaplan I (2008) Major salivary gland output differs between users and non-users of specific medication categories. Gerodontol 25: 210-216.
30. Ship JA (2002) Diagnosing, managing, and preventing salivary gland disorders. Oral Dis 8: 77-89.
31. Scully C (2003) Drug effects on salivary glands: dry mouth. Oral Dis 9: 165-176.
32. Thomson WM, Chalmers JM, Spencer AJ, Williams SM (1999) The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health 16: 12-17.
33. Thomson WM, Williams SM (2000) Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 46-50.
34. Thomson WM, Chalmers JM, Spencer AJ, Slade GD (2000) Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent 60: 12-20.
35. Thomson WM, Chalmers JM, Spencer AJ, Slade GD, Carter KD (2006) A longitudinal study of medication exposure among older people. Gerodontology 23: 205-213.
36. Aps JKM, Martens LC (2005) Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int 150: 119-131.
37. Navazesh M, Christensen CM (1982) A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 61: 1158-1162.
38. Samaranayake LP, Wilkieson CA, Lamey PJ, MacFarlane TW (1995) Oral disease in the elderly in long-term hospital care. Oral Dis 1: 147-151.
39. Mazengo MC, Söderling E, Alakuijala P, Tiekso J, Tenovuo J, Simell O et al (1994) Flow rate and composition of whole saliva in rural and urban Tanzania with special reference to diet, age, and gender. Caries Res 28: 468-476.
40. Johansson AK, Johansson A, Unell L, Ekbäck G, Ordell S, Carlsson GE (2009) A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. Eur J Oral Sci 117: 13-19.
41. Thomson WM, Poulton R, Broadbent JM, Al-Kubaisy S (2006) Xerostomia and medications among 32-years-olds. Acta Odontol Scand 64: 249-254.
42. Khosravani N, Birkhed D, Ekström J (2009) The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study. Eur J Oral Sci 117: 209-217.
43. Meurman JH, Tarkkila L, Tiitinen A (2009) The menopause and oral health. Maturitas 63: 56-62.
44. Handelman SL, Baric JM, Mark MS, Espeland MA, Berglund KL (1986) Prevalence of drugs causing hyposalivation in an institutionalized geriatric population. Oral Surg Oral Med Oral Pathol 62: 26-31.
45. Simons D, Brailsford SR, Kidd EAM, Beighton D (2002) The effect of medicated chewing gums on oral health in frail older people: a 1-year clinical trial. J Am Geriatr Soc 50: 1348-1353.
46. Berk L (2008) Systemic pilocarpine for treatment of xerostomia. Exp Opin Drug Metab Toxicol 4: 1333-1340.
47. Weber J, Keating GM (2008) Cevimeline. Drugs 68: 1691-1698.
48. Vissink A, Burlage FR, Spijkervet FKL, Veerman ECI, Nieuw Amerongen AV (2004) Prevention and treatment of salivary gland hypofunction related to head and neck radiation therapy and chemotherapy. Support Cancer Ther 1: 111-118.
49. Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T et al (2006) Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: fluorides. Oral Oncol 42: 934-945.